| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Alto Neuroscience, Inc. | Director | Stock Option (right to buy) | 1,540 | $4,882 | $3.17 | 01 Feb 2024 | Direct |
| Alto Neuroscience, Inc. | Director | Common Stock | 47,709 | 06 Feb 2024 | Direct | ||
| Alto Neuroscience, Inc. | Director | Series B Preferred Stock | 0 | 06 Feb 2024 | Direct | ||
| Alto Neuroscience, Inc. | Director | Series C Preferred Stock | 0 | 06 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANRO | Alto Neuroscience, Inc. | 06 Feb 2024 | 4 | $0 | 4 | Director | 07 Feb 2024, 16:35 |
| ANRO | Alto Neuroscience, Inc. | 01 Feb 2024 | 2 | +$18,301 | 4 | Director | 05 Feb 2024, 16:43 |
| ANRO | Alto Neuroscience, Inc. | 01 Feb 2024 | 0 | $0 | 3 | Director | 01 Feb 2024, 18:43 |